Field & Main Bank Bristol Myers Squibb CO Transaction History

Field & Main Bank

$278 Million
Q3 2024

A detailed history of Field & Main Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Field & Main Bank holds 12,606 shares of BMY stock, worth $731,148. This represents 0.23% of its overall portfolio holdings.

Number of Shares

12,606

Previous 13,656 7.69%

Holding current value

$731,148

Previous $567,000 14.99%

% of portfolio

0.23%

Previous 0.21%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$39.66 - $51.75 $41,643 - $54,337	-1,050 Reduced 7.69%	12,606 $652,000
Q2 2024 Jul 25, 2024	SELL	$40.25 - $52.99 $22,137 - $29,144	-550 Reduced 3.87%	13,656 $567,000
Q1 2024 Apr 29, 2024	SELL	$47.98 - $54.4 $22,838 - $25,894	-476 Reduced 3.24%	14,206 $770,000
Q4 2023 Feb 05, 2024	SELL	$48.48 - $57.85 $50,661 - $60,453	-1,045 Reduced 6.64%	14,682 $753,000
Q3 2023 Oct 12, 2023	BUY	$57.89 - $64.73 $233,007 - $260,538	4,025 Added 34.4%	15,727 $912,000
Q2 2023 Jul 26, 2023	SELL	$63.71 - $70.74 $3,185 - $3,536	-50 Reduced 0.43%	11,702 $748,000
Q1 2023 Apr 19, 2023	SELL	$65.71 - $74.53 $9,199 - $10,434	-140 Reduced 1.18%	11,752 $814,000
Q4 2022 Jan 19, 2023	SELL	$68.48 - $81.09 $3,424 - $4,054	-50 Reduced 0.42%	11,892 $0
Q3 2022 Oct 25, 2022	SELL	$0.13 - $76.84 $28 - $16,981	-221 Reduced 1.82%	11,942 $849,000
Q2 2022 Jul 18, 2022	BUY	$72.62 - $79.98 $181,259 - $199,630	2,496 Added 25.82%	12,163 $937,000
Q1 2022 Apr 21, 2022	SELL	$61.48 - $73.72 $9,529 - $11,426	-155 Reduced 1.58%	9,667 $706,000
Q4 2021 Feb 01, 2022	SELL	$53.63 - $62.52 $61,674 - $71,898	-1,150 Reduced 10.48%	9,822 $612,000
Q3 2021 Oct 14, 2021	SELL	$59.17 - $69.31 $7,100 - $8,317	-120 Reduced 1.08%	10,972 $649,000
Q2 2021 Jul 15, 2021	SELL	$61.91 - $67.42 $3,033 - $3,303	-49 Reduced 0.44%	11,092 $741,000
Q1 2021 Apr 30, 2021	BUY	$59.34 - $66.74 $5,934 - $6,673	100 Added 0.91%	11,141 $703,000
Q4 2020 Feb 25, 2021	SELL	$57.74 - $65.43 $61,204 - $69,355	-1,060 Reduced 8.76%	11,041 $685,000
Q3 2020 Oct 22, 2020	BUY	$57.43 - $63.64 $19,813 - $21,955	345 Added 2.93%	12,101 $730,000
Q2 2020 Aug 12, 2020	BUY	$54.82 - $64.09 $66,058 - $77,228	1,205 Added 11.42%	11,756 $691,000
Q4 2019 Feb 03, 2020	BUY	$49.21 - $64.19 $71,108 - $92,754	1,445 Added 15.87%	10,551 $677,000
Q3 2019 Nov 07, 2019	SELL	$42.77 - $50.71 $52,564 - $62,322	-1,229 Reduced 11.89%	9,106 $462,000
Q2 2019 Jul 22, 2019	SELL	$44.62 - $49.34 $52,428 - $57,974	-1,175 Reduced 10.21%	10,335 $469,000
Q1 2019 Apr 24, 2019	SELL	$45.12 - $53.8 $158,145 - $188,569	-3,505 Reduced 23.34%	11,510 $549,000
Q3 2018 Oct 23, 2018	SELL	$55.19 - $62.25 $8,278 - $9,337	-150 Reduced 0.99%	15,015 $932,000
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $49,519 - $61,720	980 Added 6.91%	15,165 $891,000
Q1 2018 May 01, 2018	SELL	$59.92 - $68.98 $17,976 - $20,694	-300 Reduced 2.07%	14,185 $0
Q4 2017 Jan 24, 2018	BUY	$59.94 - $65.35 $868,230 - $946,594	14,485	14,485 $887,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Field & Main Bank, based on Form 13F filings with the SEC.

News

Stay updated on Field & Main Bank with notifications on news.

Account